Merck KGaA header image

Merck KGaA

MRK

Equity

ISIN DE0006599905 / Valor 412799

Xetra (2026-08-11)
EUR 140.00-2.44%

Merck KGaA
UMushroom community rating:

star star star star star
3.00 2 votes No rating yet
NegativeNeutralPositive

About company

Merck KGaA is a global science and technology company headquartered in Darmstadt, Germany, with a history spanning more than 350 years. The company operates across three business sectors: Life Science, Healthcare, and Electronics. In the Life Science sector, Merck provides a wide range of laboratory tools, services, and solutions that support scientific research and bioprocessing for drug manufacturing. The Healthcare division focuses on developing and delivering treatments for serious diseases, including oncology, neurology, immunology, fertility, and endocrinology. Meanwhile, the Electronics sector offers advanced materials, technologies, and solutions for the semiconductor, display, and surface solutions industries. With approximately 63,000 employees in 65 countries, Merck KGaA is dedicated to leveraging science and technology to improve access to health, empower scientific research, and drive human progress through innovation in its diverse fields of operation.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

29.6%1Y
-14.3%3Y
-25.5%5Y

Performance

29.5%1Y
27.5%3Y
28.4%5Y

Volatility

Market cap

20887 M

Market cap (USD)

Daily traded volume (Shares)

240,880

Daily traded volume (Shares)

1 day high/low

139.95 / 138.35

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.00

2 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.50
Tobias Kurz
Switzerland, 30 Mar 2025
star star star star star
-
Theo Clausen
Switzerland, 25 Sep 2024
star star star star star
Currently in a downtrend due to france results, but might surprise us in the future.

EQUITIES OF THE SAME SECTOR

Interparfums Inc
Interparfums Inc Interparfums Inc Valor: 833467
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%USD 120.04
Perrigo Company PLC
Perrigo Company PLC Perrigo Company PLC Valor: 22008864
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.66%USD 12.85
Staar Surgical Co
Staar Surgical Co Staar Surgical Co Valor: 972813
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.72%USD 24.94
PTC Therapeutics Inc
PTC Therapeutics Inc PTC Therapeutics Inc Valor: 2515234
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.25%USD 73.70
Penumbra Inc
Penumbra Inc Penumbra Inc Valor: 29290920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.09%USD 326.28
Divi's Laboratories Limited
Divi's Laboratories Limited Divi's Laboratories Limited Valor: 3132723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.17%INR 8,537.00
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%USD 94.99
LivaNova PLC
LivaNova PLC LivaNova PLC Valor: 28726218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.75%USD 78.58
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%USD 11.61
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.65%USD 15.12